SKI Market

Indian Indices

Sensex

81,537.70 -769.67
( -0.94%)

Global Indices

Nasdaq

49,128.98 -276.04
(-0.56%)

Dow Jones

6,938.97 4.62
(0.07%)

Hang Seng

53,831.56 142.67
(0.27%)

Nikkei 225

10,138.52 -11.53
(-0.11%)

Forex

USD-INR

91.58 0.09
(0.10%)

EUR-INR

107.27 0.14
(0.13%)

GBP-INR

123.20 0.33
(0.27%)

JPY-INR

0.58 0.00
(-0.17%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Avasara Finance Ltd

Industry : Finance & Investments

BSE Code

ISIN Demat

Book Value()

511730

INE759D01017

7.7547375

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

24.57

EPS(TTM)

Face Value()

Div & Yield %

Back

Dr Reddy's Laboratories consolidated net profit declines 14.42% in the December 2025 quarter

Jan 21,2026

Net profit of Dr Reddy's Laboratories declined 14.42% to Rs 1209.90 crore in the quarter ended December 2025 as against Rs 1413.70 crore during the previous quarter ended December 2024. Sales rose 4.41% to Rs 8727.00 crore in the quarter ended December 2025 as against Rs 8358.60 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	8727.00	8358.60	4
OPM %	21.63	27.19	-
PBDT	2064.20	2345.70	-12
PBT	1543.20	1874.30	-18
NP	1209.90	1413.70	-14

81,537.70 -769.67 ( -0.94%)

49,128.98 -276.04 (-0.56%)

6,938.97 4.62 (0.07%)

53,831.56 142.67 (0.27%)

10,138.52 -11.53 (-0.11%)

91.58 0.09 (0.10%)

107.27 0.14 (0.13%)

123.20 0.33 (0.27%)

0.58 0.00 (-0.17%)